StimCell Energetics Inc. (STME)
| Market Cap | 5.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -566.29K |
| Shares Out | 20.52M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 767 |
| Average Volume | 175 |
| Open | 0.2700 |
| Previous Close | 0.2700 |
| Day's Range | 0.2700 - 0.2700 |
| 52-Week Range | 0.0015 - 0.5850 |
| Beta | 42.48 |
| RSI | 43.06 |
| Earnings Date | Aug 29, 2025 |
About StimCell Energetics
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controlle... [Read more]
Financial Performance
Financial StatementsNews
StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / March 26, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness...
StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use
Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:ST...